Jiangsu Pacific Meinuoke Bio-pharmaceutical Co., Ltd (PMBP) is a privately-owned company dedicated to developing innovative and affordable biopharmaceuticals for patients with oncology and infectious diseases. We offer a wide range of services, including early target identification, lead identification and optimization, process development, GMP manufacturing, and preclinical and clinical testing for global registration and marketing. Our competitive advantage stems from our collaboration with the National Translational Science Center for Molecular Medicine, a leading institution in basic research for innovative biopharmaceuticals in China.

By enhancing technologies development, providing high-quality manufacturing, and retaining our competence in non-clinical and clinical investigation, we ensure the timely handling of regulatory affairs and marketing. At Pacific Meinuoke, we prioritize patient welfare and consider it our ethical responsibility to provide therapeutic medicines for patients with unmet needs. Our social responsibility lies in delivering high-quality affordable medicines to ensure efficient and safe treatments.

Stay up to date on the latest developments from Pacific Meinuoke as we continue to bring hope and healing to patients worldwide